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Abstract
The evolutionary demand for rapid nerve impulse conduction led to the process of myelination-
dependent organization of axons into distinct molecular domains. These domains include the node
of Ranvier flanked by highly specialized paranodal domains where myelin loops and axolemma
orchestrate the axoglial septate junctions. These junctions are formed by interactions between a glial
isoform of neurofascin (NfascNF155) and axonal Caspr and Cont. Here we report the generation of
myelinating glia-specific NfascNF155 null mouse mutants. These mice exhibit severe ataxia, motor
paresis, and death before the third postnatal week. In the absence of glial NfascNF155, paranodal
axoglial junctions fail to form, axonal domains fail to segregate, and myelinated axons undergo
degeneration. Electrophysiological measurements of peripheral nerves from NfascNF155 mutants
revealed dramatic reductions in nerve conduction velocities. By using inducible PLP-CreER
recombinase to ablate NfascNF155 in adult myelinating glia, we demonstrate that paranodal axoglial
junctions disorganize gradually as the levels of NfascNF155 protein at the paranodes begin to drop.
This coincides with the loss of the paranodal region and concomitant disorganization of the axonal
domains. Our results provide the first direct evidence that the maintenance of axonal domains requires
the fence function of the paranodal axoglial junctions. Together, our studies establish a central role
for paranodal axoglial junctions in both the organization and the maintenance of axonal domains in
myelinated axons.
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The anatomical organization of myelinated axons into distinct molecular domains is the basis
for rapid propagation of action potentials in a saltatory manner (Hartline and Colman, 2007).
Although the signal transduction mechanisms that underlie the axonal organization into
specific domains (i.e., the node, the paranode, the juxtaparanode, and the internode) are poorly
understood, considerable progress has been made in identifying key molecular components
within these axonal domains. The paranodal region is unique in its organization and
ultrastructural characteristics and contains specialized axoglial junctions referred to as the
paranodal axoglial septate junctions, which resemble the ladder-like invertebrate septate
junctions (Einheber et al., 1997; Pedraza et al., 2001; Banerjee et al., 2006a, b). Three major
paranodal proteins have been identified: Caspr or paranodin (Einheber et al., 1997; Menegoz
et al., 1997; Peles et al., 1997; Bhat et al., 2001), and a GPI-anchored neural cell adhesion
molecule Contactin (Cont; Berglund et al., 1999; Boyle et al., 2001) on the axonal side, and
the 155-kDa neurofascin isoform (NfascNF155) on the glial side (Tait et al., 2000; Charles et
al., 2002). Although NfascNF155 is the only known glial paranodal protein, many proteins
expressed in myelinating glia are required at some level in the formation and/or stability of the
paranodal junctions (Coetzee et al., 1996; Griffiths et al., 1998; Ishibashi et al., 2002; Lappe-
Siefke et al., 2003; Southwood et al., 2004; Rasband et al., 2005).
Mutational analysis of Caspr and Cont loci revealed their essential roles in the formation of
paranodal axoglial junctions and segregation of Na+ and K+ channels at the nodes and
juxtaparanodes, respectively (Bhat et al., 2001; Boyle et al., 2001). Myelinated axons of
Caspr mutants displayed disorganized paranodal regions with axonal cytoskeletal
disorganization, resulting in organelle accumulation and axonal degeneration (Bhat et al.,
2001; Einheber et al., 2006; Garcia-Fresco et al., 2006; Pillai et al., 2007 On the axonal
cytoskeletal side, the cytoplasmic domain of Caspr assembles a protein complex that includes
band 4.1B, αII and βII spectrins, and ankyrin B (Denisenko-Nehrbass et al., 2003; Garcia-
Fresco et al., 2006; Ogawa et al., 2006). The localization of these proteins at the paranodes in
Caspr mutants is disrupted, suggesting that Caspr is required for the formation of this paranodal
cytoskeletal complex (Garcia-Fresco et al., 2006).
Recently, Nfasc mutants lacking both the glial NfascNF155 and the neuronal NfascNF186
isoforms were generated, and transgenic rescue of the glial and neuronal Nfasc isoforms
indicated specific function of these isoforms in nodal organization (Sherman et al., 2005; Zonta
et al., 2008). The Nfasc mutants died at about postnatal day (P) 6, when paranodal and nodal
organization has not been completed and myelination is still taking place. This early lethality
combined with the loss of both NfascNF155 and NfascNF186 isoforms has hampered a detailed
phenotypic analysis to determine the specific role of glial NfascNF155 in the formation and
function of the axoglial junctions. In this study, using embryonic and adult gene disruption
strategies, we have specifically addressed the role of myelinating glia-specific NfascNF155 in
the formation and maintenance of the paranodal axoglial junctions, without affecting the
function of neuronal NfascNF186. We show that embryonic loss of glial NfascNF155 in mice
results in motor coordination defects, loss of paranodal axoglial junctions, a significant delay
in nerve conduction velocity, and lethality at P17. We further demonstrate that ablation of
NfascNF155 in adult myelinating glia results in a gradual loss of paranodal axoglial junctions
and a concomitant disorganization of the axonal domains. Together our results establish that
paranodal axoglial junctions are central to domain organization and maintenance in myelinated
axons.
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All animal experiments were carried out according to UNC-IACUC-approved guidelines for
ethical treatment of laboratory animals. Transgenic mice used in this study expressing Cre
recombinase from the Cnp locus (Cnp-Cre; Lappe-Siefke et al., 2003), the P0 promoter (Feltri
et al., 1999), and inducible Plp-CreER (Doerflinger et al., 2003) were generously provided by
Drs. Klaus Nave (Max Planck Institute of Experimental Medicine), Laura Feltri (San Rafaele
Scientific Institute, Italy), and Brian Popko (University of Chicago), respectively.
Conditional Targeting of Nfasc Gene
The neurofascin (Nfasc) gene spans ~171 kb of the genomic DNA and generates many
alternative spliced mRNAs (refer http://www.ensemble.org/mouse). To ablate Nfasc gene
expression and function conditionally, a targeting construct was generated in which loxP sites
were targeted to flank exons 2 and 3 of the Nfasc gene. A BAC clone (bMQ228D3) from a
129 AB2.2 BAC library containing the targeted Nfasc exons was obtained from the Sanger
Center, England. With BAC recombineering technology, a polymerase II promoter directed
diphtheria toxin (DT) vector containing short PCR-generated arms homologous to those of the
Nfasc DNA sequence was transformed into Escherichia coli DY380 recombinant bacterial
strain (heat-induced RED and GAM recombinase complex) containing the Nfasc BAC. By this
approach, an ~9.4-kb fragment from Nfasc BAC was successfully retrieved into the DT vector
by means of gap repair. The first loxP site was inserted into intron 3 by transforming a PGK-
neo cassette flanked with loxP sites. This confers kanamycin resistance to DT-Nfasc plasmid.
The DT-Nfasc clone with proper neo cassette integration was transformed into strain EL350,
and, upon arabinose-induced Cre recombination in transformed EL350, the neo cassette was
removed, leaving the loxP site in intron 3. Similar steps were repeated for the insertion of
another neo cassette flanked with FRT and FRT-loxP sites into intron 1. Prior to ES cell
targeting, the functionality of the loxP sites as well as the expected restriction enzyme digestion
patterns in the targeting vector was confirmed. The targeting construct was linearized with
NotI, followed by electroporation into ES cells. The targeted ES cells were screened by PCR
amplification and standard molecular biological methods (for details see Bhat et al., 2001).
Antibodies, Immunofluorescence, and Immunoblotting
Three antisera were generated against the two Nfasc protein isoforms as follows. Sequences
corresponding to the NfascNF155-specific fibronectin III domain 3 (amino acids KIRV--ASFP),
the NfascNF186-specific mucin domain (amino acids TVGT--VYSR), and the common
cytoplasmic region (amino acids FIKR--YSLA) were used to immunize guinea pigs and rats
as previously described (Bhat et al., 1999, 2001). Other primary antibodies used were guinea
pig anti-Caspr antibodies (Bhat et al., 2001), rabbit anticalbindin, mouse pansodium channel,
rabbit and mouse antipotassium channel (Kv1.1; Sigma, St. Louis, MO), mouse anti-β-tubulin
(Chemicon, Temecula, CA), mouse anti-PLP (ABR Bioreagents), mouse anti-MBP (Sterberger
Monoclonals, Lutherville, MD), rabbit anti-NrCAM (Abcam, Cambridge, MA), rat anti-PLP
(A. Gow, Wayne State University), and rabbit anti-Cont (J. Salzer, NYU; Rios et al., 2000).
The secondary antibodies conjugated to Alexa Fluors-488, -568 and -647 were obtained from
Invitrogen Corporation (La Jolla, CA).
Preparation of Teased Sciatic Nerves and Cerebellar and Spinal Cord Sections
Fixed sciatic nerves were teased into individual fibers in ice-cold PBS, mounted on glass slides,
and dried overnight at RT, followed by treatment with acetone at −20°C for 20 min. The slides
were washed with PBS several times before immunostaining; in some cases, slides were stored
at −80°C until processed further. For cerebellar and spinal cord sections, wild-type and mutant
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mice were deeply anesthetized and transcardially perfused with saline buffer followed by a
solution of 4% paraformaldehyde in PBS. For immunofluorescence, cerebelli or spinal cords
were sectioned on a Vibratome (Leica) at 30 µm thickness and processed as previously
described (Garcia-Fresco et al., 2006).
Transmission Electron Microscopy
TEM was carried out essentially as described by Garcia-Fresco et al. (2006). After intracardiac
perfusion, the whole animal was postfixed for 2 weeks at 4°C in the same fixation solution.
After an overnight incubation in Millonig’s buffer, nerve fibers, spinal cords, or cerebellar
tissue from each animal was postfixed for 1 hr in cacodylate-buffered 1% osmium tetroxide.
The tissue was then rinsed, dehydrated in increasing concentrations of cold ethanol, and
infiltrated and embedded in PolyBed (Polysciences, Warrington, PA). One-micrometer and
ninety-nanometer sections were cut and stained with to-luidine blue or a combination of uranyl
acetate and lead citrate, respectively. The 1-µm-thick sections were analyzed with a Nikon
Eclipse 800, and the 90-nm-thick sections were analyzed with a JEOL JEM1230 transmission
electron microscope equipped with a Gatan Ultrascan digital camera for acquiring images at
high resolution.
Image Analysis and Quantitation
Confocal images were captured with a Bio-Rad Radiance 2000 laser scanning system attached
to a Zeiss Axioplan2 microscope. The immunofluorescence images shown are Z stacks of five
to eight sections with a scan step of 0.25 µm. All scanning parameters were optimized for the
wild-type tissues, and the mutant tissues were scanned at identical settings. Quantitative
measurements were performed on at least three independent tissue samples for
immunofluorescence analysis and two independent samples for TEM analysis. For paranodal
numbers and length estimation, only those paranodes were counted that looked
morphologically normal and did not display structural distortions or stretching as a result of
teasing of the fibers during preparation.
Tamoxifen-Induced Nuclear Translocation of CreER Recombination
The tamoxifen induction experiments were carried out essentially according to Doerflinger et
al. (2003). Animals of the genotype Plp-CreER;NfascFlox/+ and Plp-CreER;NfascFlox were
intraperitoneally injected with 100 µl of suspension (=1 mg tamoxifen) for 10 consecutive days
beginning at P23. The animals were then sacrificed at various time points for phenotypic
analysis by light and electron microscopy and for electrophysiological measurements.
Electrophysiological Studies
Age-matched wild-type, Cnp-Cre;NfascFlox/Flox, P0- Cre;NfascFlox/Flox, and Plp-
CreER;NfascFlox/Flox mutant mice were deeply anesthetized with Avertin or sacrificed by
cervical dislocation. Left tibial/plantar nerves (mean length 13.5 mm) were carefully dissected
free, cleaned of excess connective tissue, and maintained in cooled, oxygenated, modified
Bretag’s solution (123 mM NaCl, 3.5 mM KCl, 0.7 mM MgSO4, 2 mM CaCl2, 9.5 mM Na
gluconate, 1.7 mM NaH2PO4, 5.5 mM glucose, 7.5 mM sucrose, 10 mM HEPES; pH 7.40,
osmolarity 290) for 2 hr to permit recovery from the acute injury of the dissection. In a dual-
compartment ex vivo recording chamber (Stampfli, 1954; Reeh, 1986), the nerves were
superfused in oxygenated Bretag’s solution at 30°C. Rectangular wave pulses (0.01 msec) were
delivered by an Ag/AgCl suction electrode to the proximal portion of the nerve. One millimeter
of the distal portion of the nerve was pulled out of the solution, suspended in a layer of mineral
oil, and positioned on a gold recording electrode. A reference electrode was placed in solution
close to the gold recording electrode. Evoked compound action potentials (CAP) were
amplified and stored as digitized signals with pClamp 10.2 software (Molecular Devices, Union
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City, CA). Amplitude of the stimulus pulses (10–30 V) was adjusted to ensure a near-maximal
stimulation of the A-component of the CAP (Gasser and Grundfest, 1939). In other words, the
nerve was stimulated at an intensity sufficient to elicit a stable A-component amplitude and
latency. Conduction latency was measured as the time in milliseconds from the start of the
stimulus artifact to the start of the first upward deflection of the A-component. Conduction
velocity (m/sec) was calculated as the distance between the stimulating and recording
electrodes divided by the conduction latency.
RESULTS
Generation and Phenotypic Characterization of Myelinating Glia-Specific Neurofascin
(NfascNF155) Null Mutants
The main molecular components of the paranodal axoglial junctional complex include Caspr
and its cis interacting partner Cont on the axonal side and the NfascNF155 on the glial side (Fig.
1A; Peles and Salzer, 2000;Pedraza et al., 2001;Bhat, 2003;Salzer, 2003). Recently, Nfasc
mutants were generated revealing that Nfasc is required for the formation of paranodal axoglial
junctions and organization of the node of Ranvier (Sherman et al., 2005). We first determined
the molecular differences between the glial and the neuronal isoforms of Nfasc by analyzing
the reported Nfasc cDNA sequences and the mouse genomic DNA databases (for details see
http://www.ensembl.org/mouse). This analysis revealed that the major Nfasc isoforms contain
28 exons, with NfascNF155 containing exons 20 and 21, encoding the third fibronectin (FN) III
domain (Fig. 1B, exons in gray). NfascNF186 instead contains exons 23 and 24, which are absent
in NfascNF155, encoding the mucin (MUC) domain (Fig. 1B, exons in dark gold; Davis et al.,
1996;Tait et al., 2000).
To ablate the function of NfascNF155 specifically without interfering with the function of
NfascNF186, we first analyzed the structure of the 5′ region of the Nfasc locus. We generated a
targeting construct (NfascFlox) such that the coding exons 2 and 3 were flanked by loxP sites.
Myelinating glia-specific Cre-mediated recombination resulted in the deletion of exons 2/3,
causing translation termination of NfascNF155 in exon 4 (Fig. 1C). A 30-amino-acid polypeptide
from the putative initiation codon and 20 unrelated amino acids were produced as a result of
frame shift without affecting neuronal NfascNF186 expression (Fig. 1C, red asterisk). A detailed
strategy for the generation of the NfascFlox targeting construct is given in Materials and
Methods. After germline transmission, heterozygous and homozygous mice were confirmed
by PCR amplification across the targeted region. The primer combinations and the products
of the PCR amplification from wild-type (+/+), NfascFlox/+, NfascFlox/Flox, and Cnp-Cre-
mediated deletion of the floxed exons are shown in Figure 1D. The PCR amplification using
primer sets 1 and 4 confirmed that both exons 2 and 3 were deleted in Cnp-cre/
+;NfascFlox/Flox (Fig. 1D).
To ablate the expression of NfascNF155 specifically in the myelinating glial cells in the CNS
and PNS, we used two well-established myelinating glia-specific Cre lines, Cnp-cre (Lappe-
Siefke et al., 2003) and myelin P0-cre (Feltri et al., 1999). The mice of the genotype Cnpcre/
+;NfascFlox/Flox, in which only NfascNF155 has been ablated in both the Schwann cells and the
oligodendrocytes, are born at the expected Mendelian frequency from heterozygous
intercrosses. The NfascNF155 mutant mice are indistinguishable from their wild-type littermates
until approximately P8. Starting at about P12, the mice become identifiable by their smaller
stature and progressive neurological defects that reach maximal severity toward the beginning
of the third postnatal week, and all mutants die at about P16/17. A typical P16 Cnpcre/
+;NfascFlox/Flox animal has a posture shown in Figure 1F and is easily differentiated from the
wild type shown in Figure 1E. At P16, the defects include hypomotility and severe motor
coordination defects. These mice fail to maintain their balance on a stationary beam and are
nearly immobile in open field tests (data not shown). We monitored the weight of the Cnp-cre/
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+;NfascFlox/Flox animals and compared it with that of their wild-type littermates. As shown in
Figure 1G, at about P6, the wild-type and Cnp-cre/+;NfascFlox/Flox littermates are of almost
identical weight, but, from P8 onward, the Cnp-cre/+;NfascFlox/Flox animals begin to show
progressive loss of weight, and, by P16/17, the weight of the Cnp-cre/+;NfascFlox/Flox animals
falls below what they had weighed at P6. The Cnp-cre/+;NfascFlox/+ are indistinguishable
from their wild-type littermates and live a normal life span without displaying any physical or
behavioral phenotypes. In contrast to Nfasc mutants reported by Sherman et al. (2005), which
die at P6 when paranodal and nodal organization is just taking place, our Cnpcre/
+;NfascFlox/Flox mice die at P16/17, emphasizing the role of individual Nfasc isoforms in
paranodal and nodal organization.
To demonstrate that we had specifically generated an NfascNF155 null allele in myelinating
glia, we carried out Western blot analysis using antisera generated against the C-terminal
domain of Nfasc (NFCT), which recognizes both NfascNF155 and NfascNF186. As shown in
Figure 1H, the wild-type (+/+) spinal cord lysate shows both NfascNF155 and NfascNF186
protein isoforms (arrows), whereas Cnp-cre/+;NfascFlox/Flox animals show only the
NfascNF186 isoform and lacks the NfascNF155 isoform (red asterisk). These results indicate
specific loss of NfascNF155 in the myelinating glial cells. To establish that the NfascNF155
isoform is absent from the paranodes of the myelinated axons, we immunostained teased sciatic
nerve fibers with isoform-specific antibodies against NfascNF155 and NfascNF186 (Fig. 1B). As
shown in Figure 1I,J and in the merged image in Figure 1I″, wildtype (+/+) fibers showed
specific paranodal localization of NfascNF155 (Fig. 1I, green), and nodal localization of
NfascNF186 (Fig. 1I′, red). The Cnp-cre/+;NfascFlox/Flox mutant sciatic nerve fibers lacked
immunoreactivity against NfascNF155 (Fig. 1J, green) but showed normal nodal localization of
NfascNF186 (Fig. 1J′, red) in the merged image (Fig. 1J″). Similarly P0-cre/+;NfascFlox/Flox
mice revealed loss of NfascNF155 specifically in the peripheral nerve fibers both by immunoblot
and by immunohistochemical analyses and not in the central myelinated fibers (data not
shown). Taken together, our data demonstrate that we have generated myelinating gliaspecific
NfascNF155 mutants without altering the expression and localization of NfascNF186 at the node
of Ranvier.
Axonal Domain Organization is Disrupted in NfascNF155 Mutant Myelinated Axons
To determine the relationship between expression of the Nfasc isoforms with paranodal
biogenesis, we first analyzed the developmental expression profile of NfascNF155 in myelinated
sciatic nerve fibers by using immunohistochemistry. As shown in Figure 2A, at P0,
NfascNF155 is expressed at the sites where paranodes are beginning to form. At this stage,
NfascNF186 localizes to the node, which shows a broad morphology (Fig. 2Aa, red). Similarly,
we analyzed P1, P3, P5, P10, and P15 sciatic nerves, which revealed that NfascNF155 is
expressed at the paranodes during their formation. At P10 and P15, as paranode formation is
completed, NfascNF186 localization becomes more concentrated at the node (compare Fig.
2Aa–f). We next analyzed the distribution of NfascNF155 along with the axonal paranodal
protein Caspr and nodal NfascNF186 to determine their precise colocalization during paranode
formation. As shown in Figure 2B, NfascNF155 (green) colocalizes with Caspr at the paranodes
(blue) at all postnatal developmental stages beginning with P0 through P15. The
immunoreactivity for Caspr at P0 is qualitatively lower compared with later stages. From P3
onward, NfascNF155 and Caspr showed complete colocalization (Fig. 2Bc–f). To establish the
comparative expression levels of NfascNF155 and NfascNF186 during postnatal development,
we carried out Western blot analysis of P1, P3, P6, P8, P12, and P15 spinal cords using NFCT
antibodies that recognize both isoforms. As shown in Figure 2C, NfascNF186 protein levels are
comparatively higher than NfascNF155 at early stages (Fig. 2C, compare P1 and P3). At later
stages, NfascNF155 expression levels increase compared with earlier stages and with
NfascNF186 (Schafer et al., 2006). These results are consistent with the increase in
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NfascNF155 fluorescence observed at later developmental stages in the immunohistochemical
analysis shown in Figure 2A,B. Thus NfascNF155 expression pattern coincides with paranode
formation during postnatal development.
To establish the consequence of loss of NfascNF155 in the Schwann cells in Cnp-cre/
+;NfascFlox/Flox animals, we analyzed mutant sciatic nerve fibers by coimmunostaining against
Caspr and Cont paranodal proteins along with nodal NfascNF186. Wild-type nerve fibers from
P17 animals show the expected localization of NfascNF155 at the paranodes (Fig. 2D, red), and
NfascNF186 localization at the node (Fig. 2D′, green, see also merged image in Fig. 2D″).
Similarly, immunostaining with NFCT antibodies reveals proper paranodal localization of
NfascNF155 (Fig. 2E–E″). In Cnp-cre/+;NfascFlox/Flox animals, NFCT immunoreactivity
indicates specific loss of NfascNF155 at the paranodes without affecting NfascNF186 (Fig. 2F,
red), as is seen with NfascNF186 specific immunoreactivity (Fig. 2F′, green; also shown in the
merged image in Fig. 2F″,F″′). Immunostaining against Caspr in the wild-type (Fig. 2G, red)
and Cnp-cre/+;NfascFlox/Flox animals (Fig. 2H, red) and against Cont in the wild-type (Fig. 2I,
red) and Cnp-cre/+;NfascFlox/Flox animals (Fig. 2J, red) shows that both Caspr and Cont fail
to localize at the paranodes in the Cnp-cre/+;NfascFlox/Flox animals. These results indicate that
glial NfascNF155 is essential for paranodal Caspr and Cont localization and that the localization
of nodal NfascNF186 is not affected in Cnp-cre/+;NfascFlox/Flox mutant fibers.
A hallmark of myelinated axons is the localization of voltage-gated Na+ channels at the nodes
and the delayed rectifier Shaker-type K+ channels at the juxtaparanodes and to regions of the
internode that oppose the noncompacted myelin membranes, e.g., the Schmidt-Lanterman
incisures and the internal mesaxon (Arroyo et al., 1999). To determine whether loss of
NfascNF155 at the paranodal junctions in Cnp-cre/+;NfascFlox/Flox mice affects the distribution
of these channels, we carried out immunofluorescence staining of sciatic nerves. In both wild-
type (Fig. 2K) and Cnp-cre/+;NfascFlox/Flox (Fig. 2L) mice, Na+ channels (Fig. 2K,L, green)
were restricted to the nodes of Ranvier. Unlike the localization of Na+ channels, the distribution
of the K+ channels (Fig. 2K,L, Kv1.1, red) was markedly different between the wild-type and
the Cnp-cre/+;NfascFlox/Flox mice. In wild-type nerves (Fig. 2K), K+ channels were completely
separated from the Na+ channels by the paranodal region, as expected. In contrast, Cnp-cre/
+;NfascFlox/Flox mice showed mislocalized K+ channels in the paranodal region, immediately
adjacent to and, in some cases, slightly overlapping with Na+ channels (note the areas of overlap
appear as yellow in the merged images; Fig. 2L). These data indicate that glial NfascNF155 at
the paranodal axoglial junctions is required for the segregation of Na+ and K+ channels into
distinct domains.
To characterize further the role of NfascNF155 in myelinated axons, we coimmunostained
sciatic nerve fibers from wild-type (Fig. 2M,N) and Cnp-cre/+;NfascFlox/Flox (Fig. 2O) mice
and analyzed them at low magnification. As shown in Figure 2M, an entire internodal segment
flanked with two nodes was immunostained against Na+ channels (green arrows), and
paranodes were immunostained against Caspr (blue) and K+ channels (Kv1.1, red) with distinct
localization at the juxtaparanodal region and Schmidt-Lanterman incisures (red arrows) and
inner mesaxon spanning the internodal region. Immunostaining of the wild-type sciatic nerves
with antibodies against NFCT (Fig. 2N, green), Na+ channels (Fig. 2N, blue), and K+ channels
(Fig. 2N, Kv1.1, red) revealed that NfascNF155 is strongly expressed in the internodal region
at Schmidt-Lanterman incisures (green arrows). The NfascNF155 immunoreactivity either
overlaps or is present adjacent to K+ channel immunoreactivity (Fig. 2N, red and green arrows).
Immunostaining of sciatic nerve fibers from Cnp-cre/+;NfascFlox/Flox mice revealed that
NfascNF155 immunoreactivity along the internodes at the Schmidt-Lanterman incisures is
absent (Fig. 2O, green) and that the localization of K+ channels at or near the incisures is
compromised (Fig. 2O, red). These data suggest that NfascNF155 expressed by myelinating
Schwann cells may be required for the formation of internodal specializations.
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To establish that loss of NfascNF155 also affected central myelinated axons, we carried out
immunofluorescence analysis of the spinal cords from wild-type and Cnp-cre/
+;NfascFlox/Flox mice. As shown in Figure 2P, wild-type spinal cord white matter
immunostained against NFCT (blue) and NF186 (red) showed paranodal NfascNF155 (blue)
and nodal NfascNF186 localization (pink, because both antibodies recognize NfascNF186). The
spinal cord white matter from Cnp-cre/+;NfascFlox/Flox mice, immunostained with the same
antibodies as in Figure 2P, showed no immunoreactivity against NfascNF155 but showed normal
localization of NfascNF186 (Fig. 2Q, pink), indicating specific loss of NfascNF155 in the
oligodendrocytes. We also analyzed the domain organization in the spinal cord white matter
by using coimmunostaining against Caspr (Fig. 2R,S, blue), NF186 (green) and Kv1.1 (red).
As observed in the PNS, the spinal cord also revealed loss of the paranodal domain and absence
of segregation between the juxtaparanodal and the nodal components (Fig. 2S).
To determine further whether loss of glial NfascNF155 phenocopied the presence of axonal
swellings in the cerebellar Purkinje neurons, as was observed in Caspr (Garcia-Fresco et al.,
2006; Pillai et al., 2007), Cont (Boyle et al., 2001), and CGT (Garcia-Fresco et al., 2006)
mutants, we carried out immunostaining of the cerebella from wild-type and Cnp-cre/
+;NfascFlox/Flox mice with anticalbindin antibodies. As shown in Figure 2T,U, wild-type
Purkinje neuron axons displayed normal axonal morphology. In contrast, Purkinje axons from
Cnp-cre/+;NfascFlox/Flox mice displayed extensive presence of axonal swellings (Fig. 2V,W).
These swellings are reminiscent of those observed in Caspr and CGT mutants, which we had
previously shown to be caused by cytoskeletal abnormalities and accumulation of the cellular
organelles at the disrupted paranodal regions (Garcia-Fresco et al., 2006). To establish further
that loss of glial NfascNF155 did not alter the protein expression levels of myelin or paranodal
proteins, we carried out Western blot analysis of brain lysates from wild-type and Cnp-cre/
+;NfascFlox/Flox mice. As shown in Figure 2X, the protein levels of the paranodal proteins
Caspr and Cont and the myelin proteins proteolipid protein (PLP) and myelin basic protein
(MBP) between the wild-type and Cnp-cre/+;NfascFlox/Flox mice revealed no significant
differences. These results indicate that loss of glial NfascNF155 does not alter the steady-state
levels of paranodal or myelin proteins. Taken together, our data demonstrate that loss of glial
NfascNF155 results in the disruption of the paranodal region and failure to segregate the axonal
domains in the myelinated axons.
NfascNF155 Mutants Fail To Establish Paranodal Axoglial Junctions
As established above, myelinating glia-specific loss of NfascNF155 did not alter myelin protein
levels; therefore, we wanted to determine whether histological organization of the nervous
system, including myelination, was affected. Light microscopy did not reveal any obvious
abnormalities in the histological organization or the extent of myelination (data not shown).
As shown in Figure 3, the myelinated sciatic nerve fibers from the wild-type (Fig. 3A) and
Cnp-cre/+;NfascFlox/Flox (Fig. 3B) mice were indistinguishable, and morphometric analysis
of the myelinated fibers in the PNS showed no significant differences in axon and nerve fiber
diameters, myelin thickness, or the g value (ratio of axon to fiber diameter; data not shown).
These results, together with the normal myelin protein levels (Fig. 2X), suggest that lack of
NfascNF155 does not result in any significant alterations in the myelination process.
Because immunofluorescence analysis established that NfascNF155 was localized to the myelin
side of the paranodal region, and loss of NfascNF155 specifically in myelinating glia resulted
in mislocalization of Caspr and Cont, we examined the ultrastructure of the paranodal region
in the PNS and CNS. As shown in Figure 3, low-magnification images of the sciatic nerve
nodal and paranodal regions from wild-type (Fig. 3C) and Cnp-cre/+;NfascFlox/Flox (Fig. 3D)
mice reveal no major anatomical or organizational abnormalities. At higher magnification, the
paranodal region in the wild-type showed myelin loops arrayed sequentially and in close
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apposition to the axonal membrane (Fig. 3E). Between the loops and the axon, periodic
densities corresponding to the septate-like transverse bands were readily apparent (Fig. 3E,
black arrowheads). In the Cnp-cre/+;NfascFlox/Flox sciatic nerve fibers, the organization of the
paranodal loops was preserved; however, the characteristic transverse bands were consistently
absent (Fig. 3F,G, black arrowheads). In addition, the spacing between the paranodal loops
and the axolemma was often abnormally wide, and the normal indentation of the axolemma
by the paranodal loops was often absent (compare Fig. 3F–H with E). A consistent abnormality
observed was the absence of the regular array of transverse bands between the paranodal loops
and the axon. This was further confirmed by analyzing the Schwann cell-specific P0-cre/+;
NfascFlox/Flox sciatic nerve fibers (Fig. 3I). Interestingly, the P0-cre/+; NfascFlox/Flox mice do
not show any significant peripheral neurological deficits until P90. However, it remains to be
seen whether older P0-cre/+;NfascFlox/Flox mice will develop any severe peripheral nerve
functional abnormalities. Furthermore, the Cnp-cre/+;NfascFlox/Flox sciatic nerve fibers
showed accumulation of organelles, such as mitochondria, and nodal membrane folds resulting
from cytoskeletal abnormalities at the nodal/paranodal region (Fig. 3G). Together these data
reveal that loss of NfascNF155 in Schwann cells results in the loss of paranodal axoglial septate
junctions.
Aside from the NfascNF155 localization to paranodes in the PNS, it also localizes to CNS
paranodal junctions; therefore, we examined the ultrastructure of this region in the spinal cord
and cerebella of Cnp-cre/+;NfascFlox/Flox mice. As shown in Figure 4A, in the wild-type spinal
cord white matter, the paranodal loops are arrayed in close apposition to the axonal membrane,
which establishes the septate-like transverse bands (black arrowheads). In contrast, the
paranodal loops in Cnp-cre/+;NfascFlox/Flox spinal cord white matter come in close apposition
with the axolemma, but the regular array of transverse bands between paranodal loops and the
axon is absent (Fig. 4B,C, black arrowheads). The most striking paranodal abnormalities often
observed in Cnp-cre/+;NfascFlox/Flox are the overlapping myelin loops of two adjacent
myelinating glia that obscure the nodal regions (Fig. 4D, OL). In the example shown in Figure
4D, paranodal loops from the myelin glial segment on the left (labeled OL) overlap the loops
of the myelin segment on the right. Additional defects observed in Cnp-cre/+;NfascFlox/Flox
included astrocytic processes that were interposed between the paranodal loops and the axon
(Fig. 4D, black arrows) and everted and disorganized paranodal loops that are rarely observed
at the paranodes in the wild-type spinal cords (data not shown). These data demonstrate that
loss of NfascNF155 in oligodendrocytes results in paranodal abnormalities and the loss of
paranodal axoglial junctions.
Myelinating Glia-Specific NfascNF155 Mutants Display Organelle Accumulation and
Degeneration of Cerebellar Purkinje Axons
Our immunofluorescence analysis of the cerebella from Cnp-cre/+;NfascFlox/Flox mice
revealed Purkinje neuron axonal swellings as previously observed in Cont (Boyle et al.,
2001), Caspr, and CGT mutants (Garcia-Fresco et al., 2006). To establish whether Purkinje
axons from the Cnp-cre/+;NfascFlox/Flox mice also undergo axonal degeneration and organelle
accumulation, similarly to Caspr, Cont, and CGT mutants, we carried out cross-sections of the
wild-type cerebellar white matter and found normal morphology of the myelinated axons with
no signs of any vacuolation or degeneration (Fig. 4E, black arrows). In contrast, in the Cnp-
cre/+;NfascFlox/Flox cerebellar white matter, axonal degeneration was very apparent (Fig. 4F,
black arrows). Higher magnifications revealed severe structural abnormalities and vacuolation
in the degenerating axons (Fig. 4G, black arrows). These characteristics are displayed by axons
that are in the terminal stages of degeneration (Palay and Palay, 1974). In an effort to determine
the effect of NfascNF155 deletion on the axonal structure, we performed TEM analysis of the
Purkinje axon swellings in Cnp-cre/+;NfascFlox/Flox mice. We observed large axonal
accumulations of organelles, that included mitochondria (m) and smooth endoplasmic
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reticulum (SER; Fig. 4H). These axonal accumulations dramatically altered the axonal
structure and may ultimately lead to axonal degeneration as observed in Figure 4F,G.
Consistently with our immunofluorescence data, we found that the axonal swellings were
frequently formed within or in close proximity to the paranodal region, as previously observed
in Caspr mutants (Einheber et al., 2006; Garcia-Fresco et al., 2006). Taken together, the
immunofluorescence and ultrastructural analyses show that loss of NfascNF155 at the paranodal
axoglial junctions leads to paranodal cytoskeletal disorganization and the eventual
degeneration of Purkinje axons.
Ablation of NfascNF155 in Adult Myelinating Glia (NfascNF155AD) Reveals Gradual
Disorganization of Axonal Domains
The ablation of NfascNF155 in myelinating glia during early development showed that
NfascNF155 is required for the formation of the paranodal axoglial junctions but not myelination
per se. However, these studies did not allow us to address how the axoglial junctions and axonal
domains are maintained throughout adult life in myelinated axons. To address this question,
we took advantage of a tamoxifen inducible-Cre line, developed by Doerflinger et al. (2003),
which is specifically expressed in myelinating glia (Plp-CreER) to ablate NfascNF155 during
postnatal development, when axoglial junctions and axonal domains have been well formed
and established. P23 Plp-CreER;NfascFlox/Flox mice and age-matched or littermate wild-types
were injected with tamoxifen for the next 10 days, until P33 (Fig. 5A, for details see Materials
and Methods). The myelinated sciatic nerve fibers and spinal cords of the injected mice were
analyzed by immunofluorescence over a period of 10–90 days postinjection for alterations in
NfascNF155 paranodal localization and the domain structure at the nodal/paranodal regions. As
shown in Figure 5B, at P33, Plp–CreER;NfascFlox/Flox mice showed normal paranodal
localization of NfascNF155 (green) and NfascNF186 (red). After 20 days postinjection,
NfascNF155 levels at the paranodes began to decline (Fig. 5C, green). By 40 days postinjection,
NfascNF155 levels were drastically reduced (Fig. 5D, green), and, by postinjection day 60,
NfascNF155 immunoreactivity at the paranodes was essentially absent (Fig. 5E, green). In
control mice, which also received tamoxifen, NfascNF155 localized normally to the paranodes
and was indistinguishable from that in the untreated wild types (data not shown). Next, we
followed the localization and stability of the axonal paranodal protein Caspr in control and
Plp–CreER;-NfascFlox/Flox treated mice. As shown in Figure 5F, at P33, wild-type, control
treated mice showed normal localization of Caspr (Fig. 5F, green) and nodal NfascNF186 (Fig.
5F′, red; also seen in the merged image, Fig. 5F″). In Plp–CreER;NfascFlox/Flox fibers, Caspr
immunoreactivity began to decline gradually, to the point at which only traces of paranodal
Caspr were seen by 90 days after tamoxifen injection (compare Caspr localization in Fig. 5G–
K with F). In contrast, the localization of NfascNF186 was not affected in Plp-
CreER;NfascFlox/Flox fibers (compare Fig. 5G′–K′ with F′). The Caspr immunoreactivity
present after 60 and 90 days postinjection was also observed in the nodal region overlapping
with NfascNF186 (Fig. 5J″,K″), suggesting that NfascNF155 is required to maintain Caspr
localization at the paranodes.
We then wanted to determine consequences of loss of NfascNF155 in adult myelinated fibers
on the maintenance of axonal domains, being the juxtaparanodes, the paranodes, and the nodes.
As shown in Figure 5L–L″′, wild-type control mice showed distinct localization of Kv1.1 at
the juxtaparanodes (Fig. 5L, red), Caspr at the paranodes (Fig. 5L′, blue), NfascNF186 at the
nodes (green), and together in the merged image (Fig. 5L″′). In Plp-CreER;NfascFlox/Flox
fibers, within 10 days after injection, the juxtaparanodal Kv1.1 channels (Fig. 5M, red) began
to migrate toward the nodal region. By 30 days postinjection, Kv1.1 channels (Fig. 5O, red)
had reached closer to the nodal region and began to overlap with the remaining Caspr (Fig. 5O
′, blue) at the paranodes. By 60 days after injection, no discrete paranodal region was observed;
Caspr immunoreactivity was low, and Kv1.1 channels had almost reached the node (merged
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image in Fig. 5P″′). By 90 days after injections, Kv1.1 channels essentially abutted nodal
NfascNF186, and the paranodal domain was essentially nonexistent (compare Fig. 5M″′–Q″′
with L″′). A quantitative analysis of the paranodal and other domain changes after tamoxifen
injection is presented in Table I. Together these data indicate that glial NfascNF155 is required
for the maintenance of paranodal axoglial junctions and that axoglial junctions are critical for
the maintenance of the paranodal region and axonal domains in myelinated axons.
As observed in Figure 5CH″,N″′, 20 days after injection, NfascNF155 and Caspr already show
reduced protein levels; therefore, we wanted to determine whether we could identify fibers that
were in the process of losing axonal domains, by showing partial overlap of domain markers.
As shown in Figure 5R–R″′,S–S″′, as soon as Caspr localization at the paranodes becomes
aberrant (Fig. 5R′, blue), Kv1.1 begins to migrate toward the paranodes (Fig. 5R′, red). When
Caspr localization is intact, for example, in the right paranode (Fig. 5S′, blue), Kv1.1 remains
at the juxtaparanodes (Fig. 5S, red, and S″′, merged image). The localization of NfascNF186
(Fig. 5R″,S′, green) is not affected by loss of NfascNF155. These data suggest that, as soon as
axoglial junctions begin to disassemble, axonal domain disorganization ensues, and
juxtaparanodal components begin their migration toward the nodal domain.
To determine whether central myelinated axons also follow the same pattern as the peripheral
fibers, we analyzed the spinal cord white matter in Plp-CreER;N-fascFlox/Flox mice. As shown
in Figure 5T–T″′, wild-type controls show normal domain organization, whereas the adult
animals that lose NfascNF155 show gradual disorganization of the axonal domains (Fig. 5U–
W″′). One noteworthy feature of the central fibers is that, even in the presence of robust Caspr
immunoreactivity at the paranodes (Fig. 5V′,W′, blue), the Kv1.1 channels from the
juxtaparanodes (Fig. 5V,W, red) persisted in shifting closer to the node (merged images in Fig.
5V″′,W″′). These results suggest that it is the axoglial junctions, not the mere presence of Caspr,
that maintains the axonal domains in the myelinated axons. To establish further the time line
of loss of NfascNF155 in adults after injection and the consequences of this on other paranodal
proteins, we carried out immunoblot analysis of the spinal cords from age-matched P33 wild-
type and Plp-CreER;NfascFlox/Flox tamoxifen-injected animals. As shown in Figure 5X, the
levels of NfascNF155 began to decline steadily by 10 days after injection. By 20 days
postinjection, nearly half of the NfascNF155 protein remained, and nearly none of NfascNF155
protein could be detected on the immunoblots by postinjection day 60, which is consistent with
our immunofluorescence observations (Fig. 5C–E). However, the protein levels of Caspr (Fig.
5Y) and the paranode-enriched protein 4.1B (Fig. 5Z) were not significantly affected. Taken
together, these data demonstrate that paranodal axoglial junctions are critical for the
maintenance of axonal domains in myelinated axons.
NfascNF155AD Mutants Display Gradual Loss of Paranodal Axoglial Junctions
Because the light microscopic immunofluorescence analyses in tamoxifen-injected Plp-
CreER;NfascFlox/Flox mice revealed disorganization of axonal domains, we wanted to
determine the structural changes that occur in the electron-dense transverse bands, or septa, at
the para-nodal axoglial junctions. To address this, we carried out electron microscopic
examination of spinal cord white matter and sciatic nerves of tamoxifen-injected wild-type and
Plp-CreER;NfascFlox/Flox mice. As shown in Figure 6A, P33 wild-type nerves showed normal
apposition of paranodal myelin loops with the axolemma, with distinct septa at the interface
(Fig. 6, black arrows). The region between the black arrowheads is shown at a higher
magnification in Figure 6A, inset. In contrast, the myelinated fibers from Plp-
CreER;NfascFlox/Flox 20 days after injection (Fig. 6B), showed atypical transverse bands
(septa) from the juxtaparanodal side (left in Fig. 6B), with a loosening of the junctions and
diffuse electron-dense structures in the cleft (Fig. 6B, see inset), whereas the paranodal loops
toward the nodal side (right in Fig. 6B) maintained distinct transverse bands as seen in the wild
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type (Fig. 6A). After 20 days of injection, the mutant fibers showed progressive disorganization
of the septal morphology (see Fig. 6, inset) and the axolemma detaching from the myelin loops
(Fig. 6C, asterisks). Further analysis of Plp-CreER;NfascFlox/Flox mice after 40 (Fig. 6D,E)
and 90 (Fig. 6F) days of injection, revealed that, by 40 days, some electron density is still
present in the myelin/axon cleft at the paranodes, but no presence of intact transverse bands is
observed (insets in Fig. 6D,E). By 90 days postinjection, no transverse bands were visible
between the myelin loops and the axolemma, and the electron densities noticed at earlier stages
had diminished (Fig. 6F, inset). Similarly, we analyzed the sciatic nerves from wild-type and
Plp-CreER;NfascFlox/Flox injected mice. As shown in Figure 6G, wild-type fibers displayed
typical morphology of the axoglial transverse bands (Fig. 6G, inset), whereas mutant fibers
after 20 days of injection revealed disorganization of axoglial junctions (Fig. 6H). Accordingly,
the junctions appeared to disassemble from the juxtaparanodal side (left in Fig. 6H) and
progressed gradually toward the node. As shown in Figure 6I at higher magnification, the
paranodal loops toward the nodal region side still maintain intact axoglial junctions with their
typical morphology. By 90 days after injection, all the axoglial junctions were lost (Fig. 6J,
see inset); however, electron densities on the paranodal axonal side were still observed. The
presence of these densities indicates that the remnants of the paranodal axonal scaffold that
links axoglial junctions to axonal cytoskeleton may remain intact well beyond the disruption
of axoglial junctions (Garcia-Fresco et al., 2006). Taken together, the ultrastructural analysis
reveals that the paranodal axoglial junctions disorganize gradually, and this disorganization
begins from the juxtaparanodal side and progresses gradually toward the nodal side. This
conclusion is strengthened by the observations that the juxtaparanodal components, like
Kv1.1, begin to shift toward the nodal area immediately after axoglial junctions begin to
disappear.
Peripheral Nerve Conduction Is Severely Affected in NfascNF155 and Modestly Affected in
NfascNF155AD Mutants
To determine whether the loss of the paranodal axoglial junctions and/or the altered distribution
of ion channels observed in the Cnp-Cre;NfascFlox/Flox, P0-Cre;NfascFlox/Flox, and Plp-
CreER;NfascFlox/Flox affected the electrophysiological properties of peripheral nerves, we
performed extracellular recordings from tibial/plantar nerves of litter- or age-matched wild-
type (+/+) and mutant mice. Nerves were stimulated at an intensity and duration sufficient to
elicit a stable A-component amplitude and latency (for details see Materials and Methods). The
electrophysiological measurements from various genotypes at different ages are given in Table
II, and representative plots are presented in Figure 7. In Cnp-Cre;NfascFlox/Flox nerves,
conduction velocity (CV) was reduced by 50% at P13 (8.47 m/sec compared with wild-type
at 16.83 m/sec; Fig. 7A). At P16.5, Cnp-Cre;NfascFlox/Flox fibers revealed a CV of 9.5 m/sec
compared with a wild-type CV of 17 m/sec (Fig. 7B). At P18, P0-Cre/+;NfascFlox/Flox nerves
had a 41% reduction in CV compared with wild-type (+/+, 17.9; P0-Cre, 12.6; Fig. 7C). In
addition to the substantial delay in conduction, Cnp-cre;NfascFlox/Flox nerves exhibited altered
action potential amplitude and duration. Cnp-Cre;NfascFlox/Flox demonstrated a greater than
50% decrease in amplitude and 50% increase in duration (Fig. 7A,B). This was also observed
in P0-Cre/+;NfascFlox/Flox nerves (Fig. 7C, Table II). In Plp-CreER;NfascFlox/Flox fibers, the
CV was modestly reduced, with a 24% decrease compared with wild-type (Fig. 7D). A further
reduction in CV was observed in older Plp-CreER;NfascFlox/Flox nerves (Fig. 7E, Table II).
Taken together, the electrophysiological measurements indicate an important role for
paranodal axoglial junctions in ensuring normal action potential propagation in myelinated
axons.
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The process of myelination and its ultrastructural attributes have long fascinated biologists
(Robertson, 1957). Understanding these fundamental processes, and the proteins required for
the association of glia with neurons is critical for our understanding of myelin-related
neuropathies and how they manifest. Recent work has focused on the molecular composition
of axonal domains by biochemical methods, but the role of individual components in axonal
domain organization remains elusive (Coetzee et al., 1996; Bhat et al., 2001; Boyle et al.,
2001; Sherman et al., 2005; Zonta et al., 2008). Here, by using a glial-specific conditional
knockout, we have addressed the role of NfascNF155 in the organization and maintenance of
paranodal axoglial junctions and axonal domains. Our data reveal that NfascNF155 is a critical
component of paranodal junctions and that loss of NfascNF155 in adult myelinating glia results
in the gradual loss of axoglial junctions and concomitant failure to maintain segregated axonal
domains. These mutant mice therefore provide a unique animal model for analyzing the role
of glial paranodal components in the formation, stabilization, and maintenance of axonal
domains in myelinated axons and may further contribute to our understanding of myelin-related
diseases (Fig. 8).
NfascNF155 Mutants Display Severe Motor Coordination Defects
Previous work from our laboratory has shown the importance of Caspr/paranodin to paranodal
axoglial junction formation (Bhat et al., 2001). Circumstantial evidence suggests that glial
NfascNF155 can associate with Caspr and its axonal partner Cont, but no phenotypic analysis
of a glial-specific knockout of NfascNF155 has been performed, and there is much debate over
the exact mechanism(s) of how these proteins associate (Charles et al., 2002; Gollan et al.,
2003; Bonnon et al., 2007). Here we find, with glial-specific Cnp-Cre, that NfascNF155 mutant
mice exhibit severe tremors, motor paresis, ataxia, and immobility and die at postnatal day 16
or 17, similarly to both Caspr and Cont mutant mice (Berglund et al., 1999; Bhat et al.,
2001; Boyle et al., 2001). We believe that these neurological defects reflect the function of
NfascNF155 in the myelinating glial cells and not the neuronal NfascNF186, because Cnp-Cre
expression has been shown to be restricted to glia within the CNS and PNS (Lappe-Siefke et
al., 2003). Additionally, we have shown that NfascNF186 proteins levels remain unchanged and
that the nodal complex remains intact in these animals. These findings indicate for the first
time the importance of glial-specific NfascNF155 in the formation of paranodal axoglial
junctions and in coordination of motor function.
Axon–Glial Interactions at the Nodes and Paranodes of NfascNF155 Mutants
The proposed role of glial NfascNF155 in the organization of the axoglial junctions was
suggested by the mutant phenotypes observed in Nfasc mutants that lack both NfascNF155 and
NfascNF186 (Sherman et al., 2005). These mutant mice have severe amyelination and
dismyelination as well as a reduction in the levels of myelin-specific proteins, such as MBP
and MAG (Zonta et al., 2008). In the current study, we found that glia-specific loss of
NfascNF155 did not alter the myelin ultra-structure but instead resulted in the absence of
transverse bands, the hallmark of axoglial junctions. These findings provide formal evidence
that NfascNF155 is a key glial component of axoglial junctions and is consistent with its
localization to the paranode (Tait et al., 2000; Charles et al., 2002; Sherman et al., 2005).
Interestingly, other paranodal/nodal abnormalities observed in NfascNF155 mutants are also
seen in Caspr mutants, suggesting further that loss of either of the paranodal components
generates identical phenotypes. Furthermore, the similarities in phenotype between these
mutant may be attributed to cytoskeletal abnormalities created by the disruption of the axoglial
junctions as seen previously (Einheber et al., 2006; Garcia-Fresco et al., 2006; Sousa and Bhat,
2007).
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In the CNS of NfascNF155 mutants, the morphological organization of the paranodal region is
severely affected, as evidenced by the appearance of everting and overriding glial paranodal
loops. These organizational defects can be attributed to a failure of the paranodal loops to make
physical adhesions with the axon in the NfascNF155 mutant mice. Although the paranodal loops
of these mutant mice fan outward, the structure of myelin remains unchanged and suggests that
the formation and stabilization of the paranode is independent of myelin stabilization. Upon
further examination, it was seen that the overriding loops often occluded the node (Fig. 4D),
and, although nodal proteins remain localized, such as NfascNF186, Na channels, and AnkG
(data not shown), the effect of such an obstruction on nodal function remains unknown. The
change in the paranodal structure in NfascNF155 mutants may be a result of a change in the
trapezoidal geometry of the myelin sheath, as is observed in Caspr mutants (Bhat et al.,
2001). Other striking abnormalities observed in NfascNF155 mutants are the axonal swellings
and degeneration of cerebellar Purkinje axons (Fig. 2V, W,Fig. 4F–H). In earlier studies, we
found that Caspr mutant mice exhibited similar abnormalities. We proposed then that such
phenotypes were a result of the disorganization of the paranodal axonal cytoskeleton that results
in organelle transport defects at the paranodes and eventual axonal degeneration (Einheber et
al., 2006;Garcia-Fresco et al., 2006;Sousa and Bhat, 2007). Our findings indicate further that
axoglial junction disruption leads to axonal transport defects and degeneration and indicate a
role for the glial cytoskeleton in the maintenance and stabilization of the septate-like junctions
as an anchor for the association of glia with axons.
Keeping Neighbors Apart: Paranodal Junctions and Maintenance of Axonal Domains
A major observation of this study is that the organization of axonal domains in myelinated
axons requires myelinating glia-specific expression of NfascNF155 and that, along with Caspr
and Cont, it is able to establish the transverse bands/septa required at the paranodal axon–glial
interface. Recent work has suggested that intact paranodal axoglial domains alone, formed by
reintroducing NfascNF155 into a complete Nfasc null background, may act to cluster and form
the node independent of the neuronal-specific NfascNF186 (Zonta et al., 2008). Interestingly,
these mutant mice were not able to survive past P6, the same expiry as the complete null mice
lacking both NfascNF155 and NfascNF186. Here we find that Na+ and K+ channels are able to
cluster in the absence of the glial NfascNF155 and intact paranodal junctions. This suggests that
these junctions are not required for the clustering of ion channel domains and nodal proteins
but instead are likely necessary for their continued segregation (see below). This is consistent
with previous observations demonstrating that clustering of nodal components occurs prior to
mature paranodal junction formation in the developing PNS (Melendez-Vasquez et al., 2001)
and in CGT mutant mice that fail to form paranodal axoglial junctions (Coetzee et al., 1996;
Dupree et al., 1999). Accordingly, in the absence of the paranodal axoglial junctions in
NfascNF155, Caspr, Cont, and CGT mutants, the nodal Na+ and juxtapara-nodal K+ channel
domains remain largely segregated, with only occasional overlaps into the nodal region. These
phenotypes indicate that distinct molecular interactions, possibly involving specific axonal and
glial scaffolding proteins, maintain nodal protein complexes to their respective domains (Peles
and Salzer, 2000; Pedraza et al., 2001; Bhat, 2003; Sherman and Brophy, 2005).
To address the importance of axoglial domain stabilization to the segregation of axonal
domains, i.e., the node, paranode, and juxtaparanode, in adults we utilized a tamoxifen-
inducible Plp-CreER to knock out NfascNF155 after stablilization of these domains was
complete. Upon observation, we found that, 20 days posttamoxifen injection, NfascNF155 levels
were reduced by 50% and that only after 90 days of injection is near-complete loss of
NfascNF155 seen. These findings indicate that NfascNF155 is quite stable once it is incorporated
into axoglial junctions. In addition, we found that, with increasing time after injection, Caspr
staining is gradually reduced and that the juxtaparanodal K+ channels migrated toward the
nodal region. The concomitant shift of the clustered juxtaparanodal K+ channels toward the
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node suggests that these complexes are mobile and are not anchored by, or within, the axonal/
glial cytoskeleton. However, it is unclear why the K+ channels move toward the nodal area
instead of diffusing throughout the internode; if it was a simple diffusion in the membrane,
then one would expect that they should diffuse in either direction. Interestingly, these new
findings are in direct contrast to findings from the Cnp-Cre;NfascFlox mutant mice shown here,
which fail to form paranodal axoglial junctions but still maintain segregated nodal and
juxtaparanodal domains. These results indicate that two independent functions exist to
segregate and maintain axonal domains during development and in mature animals. During
development, each axonal domain is assembled and stabilized independently of the other and
thus retains its anchorage at the respective domain, whereas, in the adult, maintenance of the
domains requires the paranode to act as a fence to segregate the domains. This suggests that,
with time, as these animals progressively lose the paranodal axoglial junctions, that both the
juxtaparanodal complex and the nodal complex may diffuse throughout the internodes, which
may lead to severe depolarization and abnormal saltatory conduction.
Conduction Velocity and the Role of Paranodal Axoglial Junctions
Electrophysiological data on NfascNF155 mutant mice generated during embryonic
development reveal that population nerve CVs are severely reduced in peripheral nerve fibers.
These defects may reflect changes in the properties of fast-conducting myelinated fibers and
may also be caused by a conduction block in a subset of fibers and/or slower propagation in
the remaining fibers. Another possibility for the weakened CVs observed in NfascNF155 mutant
mice is that the disorganized paranodal region may cause current leakage into the periaxonal
space. Leakage of the current may in turn increase the capacitance of the axonal membrane,
leading to slow action potential propagation (Chiu and Ritchie, 1980; Boyle et al., 2001).
Interestingly, it might be expected that in the adult NfascNF155 mutant mice CVs would be
slowed concomitantly with the degradation of axoglial junctions; however, we found that both
the CV and the CAP peak-to-peak amplitudes were not dramatically altered in the mutant mice
compared with control mice of the same age. These results were seen even in mice examined
6 months postinjection that had near-complete loss of NfascNF155 protein levels and
disassembled paranodal junctions (Fig. 7). It is not clear why the loss of axoglial junctions
during adult stages has a less dramatic effect on the electrophysiological properties of the
peripheral nerve fibers than loss in early developmental stages. One possibility is that many
structural features are maintained in adult mutant nerves that allow the conduction of action
potentials at near-normal or at a slightly reduced velocity. Alternatively, it could be that
different classes of fibers in these adult nerves conduct differently and what we observed is a
summation of all the fibers. It is unlikely that the reduced change in CVs is due to the injection
and variability of its penetration to all glial cells, insofar as our quantitative measurements
revealed that greater than 90–95% of the Schwann cells lost NfascNF155 after 10 days of
tamoxifen treatment (Table I), so the modest changes in CV and amplitude in adult fibers may
be due to the structural integrity of the nerve fibers and slow disorganization of the axonal
domains over time. It would be interesting to see how the NfascNF155 mutant mice CVs faired
through extended time, in that it has been shown that human demyelinating neuropathies, where
axonal domains are compromised, such as multiple sclerosis and Charcot-Marie-Tooth disease,
CVs are severely reduced (Nicholson, 1999; Wolswijk and Balesar, 2003; Coman et al.,
2006). Further studies on NfascNF155 mutant mice may reveal more similarities to human
neurological disorders and provide a system for studying human disease. In summary, we have
demonstrated that glial NfascNF155 is critical for the formation of the paranodal axoglial
junctions and that these junctions are central to the organization and maintenance of the axonal
domains in myelinated axons.
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Conditional ablation of NfascNF155 in myelinating glia. A: Main molecular components of the
paranodal axoglial junctional complex with NfascNF155 on the myelin side and Caspr and Cont
on the axonal side. Additional paranode-enriched proteins that either interact or are associated
with Caspr protein complex are also shown. B: Exon/intron structure of two major Nfasc
transcripts expressed either in myelinating glia, NfascNF155, or in neurons, NfascNF186. The
glial transcript contains unique exons numbered 20 and 21 encoding the third FNIII domain
(colored in gray) in NfascNF155. The neuronal transcript contains unique exons numbered 23
and 24 that encode a mucin domain (colored in dark gold) in NfascNF186. C: Exon/intron
structure in the 5′ region of Nfasc showing exons 1–6. The exon that encodes the putative
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initiation methionine, based on the reported protein sequences of NfascNF155 and
NfascNF186, is referred to here as exon 1. To generate a null mutation in Nfasc, a targeting
construct was engineered by using the BAC recombineering technology (Liu et al., 2003). A
1.9-kb fragment upstream of exon 2 was inserted between PolII-DT and FRT-Neo-FRT-loxP
cassette, and a second loxP site was inserted downstream of exon 3. This targeting construct,
NfascFlox, was used for ES cell transformation. The targeted ES cell clones were identified by
PCR amplification with primer sets depicted on the map. Upon Cre-mediated recombination,
~2.1 kb of genomic DNA containing exons 2 and 3 was deleted, resulting in translation
termination in exon 4 (red asterisk) that generated the NfascNull allele. D: PCR amplification
strategies using color-coded primer sets with numbers to distinguish various genotypes. Wild-
type (+/+), NfascFlox/+ (Flox/+), and NfascFlox/Flox (Flox) were distinguished by the primer
sets 3 and 4. Upon Cre-mediated deletion of ~2.1 kb of the genomic DNA containing exons 2
and 3, the primer sets 1 and 4 amplified a 3.6-kb fragment in Cnp-Cre;NfascFlox. E: Appearance
of a wild-type (+/+) mouse at P17 with normal walking posture. F: A littermate Cnp-
Cre;NfascFlox mouse is less than half the weight (3.8 vs. 9.8 g) of the wild-type mouse and
exhibits a characteristic wide base in the hind limbs. The mutant mice are severely hypomotile
and are not able to walk forward. G: The chart illustrates the weights of wild-type (+/+) and
Cnp-Cre;NfascFlox male littermates. Both genotypes at P6 have identical weight (4.2 g). The
weight of the mutant mice progressively declines, and all die before reaching P18. The weights
shown are mean of four animals in each age group. H: Immunoblot analysis of spinal cord
protein lysates from wild-type (+/+) and Cnp-Cre;NfascFlox mice using NFCT antibodies. The
wild-type lysates show two predominant protein bands migrating at 186 and 155 kDa
corresponding to NfascNF186 and NfascNF155, respectively. The Cnp-Cre;NfascFlox mutant
lysates contain the 186-kDa band, corresponding to NfascNF186, and lack the 155-kDa band,
demonstrating specific loss of NfascNF155 in Cnp-Cre;Nfasc Flox mutant mice (red asterisk).
I–I″: Immunofluorescence analysis of the sciatic nerves from wild-type (+/+) mice showing
paranodal localization of NfascNF155 (I, green) and nodal localization of NfascNF186 (I′, red)
and together in the merged image (I″). J–J″: Immunofluorescence analysis of the sciatic nerves
from Cnp-Cre;NfascFlox mutants showing loss of paranodal NfascNF155 (J, green) but normal
localization of nodal NfascNF186 (J′, red) and together in the merged image (J″) demonstrating
specific loss of NfascNF155.
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NfascNF155 mutants display abnormal localization of the paranodal proteins and
disorganization of axonal domains. A: Immunofluorescence of sciatic nerve fibers depicting
the postnatal expression profile of two Nfasc encoded protein isoforms using antibodies
generated against unique domains of NfascNF155 and NfascNF186. NfascNF155 localizes to
developing paranodes (Aa–f, green), and NfascNF186 localizes to the nodes (Aa–f, red). B:
Immunofluorescence of sciatic nerve fibers using antibodies against both NfascNF155 and
NfascNF186 (Ba–f, NFCT, green), against Caspr (CASP, blue), and against NfascNF186 (red)
during postnatal development, as in Aa–f. The paranodal colocalization of NfascNF155 and
Caspr is seen throughout postnatal development. C: Immunoblot of spinal cord lysates for a
Pillai et al. Page 21













postnatal expression profile of NfascNF155 (155 kDa) and NfascNF186 (186 kDa) using NFCT
antibodies that recognize both isoforms. NfascNF186 levels are relatively higher than
NfascNF155 levels until P3. However, longer exposures of the blots reveal the presence of
NfascNF155 at P1 as well. Equal amounts of the total protein were loaded for these immunoblots
and confirmed with antitubulin immunoblots (data not shown). D–D″: Wild-type sciatic nerve
fibers immunostained against paranodal NfascNF155 (D, red) and NfascNF186 (D′, green) and
in a merged image (D″). E–E″: Wild-type sciatic nerve fibers immunostained against NFCT
antibodies (E, NfascNF155/NfascNF186, red) and nodal NfascNF186 (E′, green) and in a merged
image (D″). Note that NFCT recognizes both NfascNF155 and NfascNF186. NfascNF186
immunoreactivity by the two antibodies appears yellow in the merged panel (E″). F–F″: Cnp-
Cre;NfascFlox sciatic nerve fibers immunostained with NFCT antibodies (F, NfascNF155/
NfascNF186, red) and nodal NfascNF186 (F′, green) and in a merged image (F″). Note that
NfascNF155 is absent from the paranodes, whereas NfascNF186 immunoreactivity with two
different antibodies remains unaffected. G–G″: Wild-type sciatic nerve fibers immunostained
against paranodal Caspr (G, CASP, red) and nodal NfascNF186 (G′, green) and in a merged
image (G″). H–H″: Cnp-Cre;NfascFlox sciatic nerve fibers immunostained against paranodal
Caspr (red) and nodal NfascNF186 (F′, green) and in a merged image (H″). Note that Caspr fails
to localize at the paranodes and is diffusely present around the nodal/paranodal region,
occasionally showing overlap with NfascNF186 (H″). I–I″: Wild-type sciatic nerve fibers
immunostained against paranodal Cont (I, red) and nodal NfascNF186 (I′, green) and in a merged
image (I″). J–J″: Cnp-Cre;Nfasc Flox sciatic nerve fibers immunostained against paranodal
Cont (J, red) and nodal NfascNF186 (J′, green) and in a merged image (J″). Note that Cont fails
to localize at the paranodes and is diffusely present around the nodal/paranodal region. K:
Wild-type sciatic nerve fibers triply immunostained against the juxtaparanodal potassium
channels (Kv1.1, red), Caspr (blue), and nodal sodium channels (NaCH, green). Note that these
proteins localize to distinct domains. L: Cnp-Cre;NfascFlox sciatic nerve fibers triply
immunostained against the juxtaparanodal potassium channels (red), Caspr (blue), and nodal
sodium channels (green). Note that the juxtaparanodal K+ channels fail to segregate from the
nodal Na+ channels. Caspr (blue) immunoreactivity is diffusely present along the axon. M:
Wild-type sciatic nerve fibers triply immunostained against Na+ channels to highlight nodes
(green arrows) flanking the entire internodal region. Caspr (blue) highlights the paranodes.
Note the K+ channel localization at the Schmidt-Lanterman incisures and the inner mesaxon
(red arrows). N: Wild-type sciatic nerve fibers triply immunostained against Na+ channels
(blue) and NFCT highlight two contiguous nodes (green arrows). Note that NfascNF155 labels
the Schmidt-Lanterman incisures (NFCT, green arrows) as well as Kv1.1 (red arrows).
NfascNF155 and Kv1.1 immunoreactivity is always observed either overlapping with or in close
proximity to each other. O: Cnp-Cre;NfascFlox sciatic nerve fibers triply immunostained
against Na+ channels (NaCH, blue) and NfascNF186 (green) highlight two nodes (green arrows).
Between the two nodes, the internodal region shows no NfascNF155 immunoreactivity. Kv1.1
(red) highlights juxtaparanodal regions and is also diffusely present along the axon. P: Wild-
type spinal cord sections against NFCT (blue) and NfascNF186 (red). NfascNF155 is in blue and
the nodal NfascNF186 is in pink, as both antibodies recognize NfascNF186. Q: Cnp-
Cre;NfascFlox spinal cord sections stained against NFCT (blue) and NfascNF186 (red).
NfascNF155 (blue) is absent, but the nodal NfascNF186 is present and indistinguishable from
the wild-type NfascNF186 (as in Q). R: Wild-type spinal cord sections stained against axonal
domain markers Kv1.1 (red), Caspr (blue), and NfascNF186 (green) show proper domain
organization. S: Cnp-Cre;NfascFlox spinal cord sections stained against axonal domain markers
Kv1.1 (red), Caspr (blue), and NfascNF186 (green) show abnormal domain organization. The
paranodal domain is compromised and Kv1.1 is almost overlapping with nodal NfascNF186,
which is never observed in the wild-type animals. T,U: A wild-type cerebellar loop
immunostained against calbindin (green) to reveal anatomical organization of various layers
and cerebellar white matter at low magnification (T) and at a higher magnification (U) with a
focus on the Purkinje axons. V,W: A Cnp-Cre;NfascFlox cerebellar loop immunostained
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against calbindin (green) to reveal the anatomical organization of various layers and cerebellar
white matter at low magnification (V) and at a higher magnification (W) with a focus on the
Purkinje axons. Note the Purkinje axonal swellings as green dots on the axons, which are never
observed in the wild-type animals. X: Immunoblots of protein lysates from wild-type (+/+)
and Cnp-Cre;NfascFlox brains against paranodal proteins (Caspr, Cont) and myelin proteins
(PLP, MBP) did not shown any significant differences in the levels of the these proteins.
Identical blots were probed with mouse antitubulin as a loading control.
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NfascNF155 mutants fail to form paranodal axoglial junctions. A,B: Electron micrographs of
cross-sections of sciatic nerves from P17 littermates wild-type (A, +/+) and Cnp-
Cre;NfascFlox (B) mice. No significant changes in myelin thickness or axon diameter were
noticed between these genotypes. C,D: Electron micrographs of longitudinal sections through
the nodal/paranodal region of sciatic nerves from P17 wild-type (C, +/+) and Cnp-
Cre;NfascFlox mutants (D). At low magnification, the paranodal myelin loops in the mutant
fibers are properly arrayed and show normal profiles as in the wild-type. E: Electron
micrograph of a longitudinal section through the paranodal region of a sciatic nerve myelinated
axon from a P17 wild-type (+/+) mouse shows paranodal loops tightly apposed to and indenting
the axon, the characteristic transverse bands are also apparent (black arrowheads). F,H:
Electron micrographs of longitudinal sections through the paranodal region of sciatic nerve
myelinated axons from a P17 Cnp-Cre;Nfasc Flox mutant mouse. Note that the paranodal loops
come in close apposition and face the axon but fail to form the transverse bands or septa with
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the axolemma. G: Electron micrograph of the nodal region from a Cnp-Cre;NfascFlox mutant
sciatic nerve fiber showing organelle build up, forming nodal pockets. Such abnormalities have
been previously observed in Caspr mutants with disrupted axoglial junctions (Einheber et al.,
2006). I: Electron micrograph of a longitudinal section through the paranodal region of a sciatic
nerve myelinated axon from a P17 P0-Cre;NfascFlox mutant mouse. These mutant fibers
display same phenotypes in the PNS as the Cnp-Cre;NfascFlox mutant fibers. Scale bars = 2
µm in A, B; 1 µm in C, D; 0.2 µm in E–I.
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NfascNF155 mutants display organelle accumulation and Purkinje neuron axonal degeneration.
A: Electron micrograph of the paranodal region of a spinal cord myelinated fiber from P17
wild-type (+/+) mouse shows paranodal loops tightly apposed to and indenting the axon; the
characteristic transverse bands are apparent (black arrowheads). B–D: Electron micrographs
of the paranodal regions of spinal cord myelinated fibers from P17 Cnp-Cre;NfascFlox mutants
show closely apposed paranodal loops but a lack of transverse bands (B,C, black arrowheads).
In D, paranodal loops from one myelin segment override loops (OL) from another segment,
thereby occluding the node (white arrow). An astrocytic process has entered the gap between
the overriding myelin loops (black arrows). E: Electron micrographs of cerebellar white matter
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from P17 wild-type (+/+) mice show normal morphology of the myelinated axons in cross-
section (black arrows). F–H: Electron micrographs of the cerebellar white matter from P17
Cnp-Cre;NfascFlox mutants show severe axonal pathology and degeneration (F, black arrows).
A myelinated axon displays vacuolated and deformed axonal cytoskeleton (G, black arrows).
A section through a Purkinje axonal swelling (H) shows accumulation of mitochondria (m)
and smooth endoplasmic reticulum (SER) caused by the disorganized paranodal axonal
cytoskeleton. Scale bars = 0.2 µm in A, B; 0.1 µm in C,D; 1 µm in E–H.
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Maintenance of axonal domains requires intact paranodal axoglial junctions. A: Experimental
strategy to create myelinating gliaspecific NfascNF155 null adult mutants. Tamoxifen was
injected into mice of desired genotypes from P23 to P33, and mice were analyzed at various
time points by immunostaining and immunoblotting. B–E: Sciatic nerves from wild-type P33
(B, +/+) and tamoxifen-injected P33 Plp-CreER;NfascFlox mice after 20 (C), 40 (D), and 60
(E) days of injection immunostained with NfascNF155 (green) and NfascNF186 (red). The levels
of NfascNF155 at paranodes begin to decrease, and it cannot be detected at 60 days after
injection. NfascNF186 levels are not affected. F–K″: Sciatic nerves from P33 wild-type (F–F
″, +/+) and tamoxifen-injected P33 Plp-CreER;NfascFlox mice after 10 (G– G″), 20 (H–H″),
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30 (I–I″), 60 (J–J″), and 90 (K–K″) days of injection immunostained with Caspr (F–K, green)
and NfascNF186 (F′–K′, red). The levels of Caspr at the paranodes begin to fall gradually and
could barely be detected at 90 days after injection. At 90 days, the remaining Caspr protein is
occasionally seen overlapping with the nodal NfascNF186 (see merged image in K′). L–Q″′:
Sciatic nerves from P33 wild-type (L–L″′, +/+) and tamoxifen-injected P33 Plp-
CreER;NfascFlox mice after 10 (M–M″′), 20 (N–N″′), 30 (O–O″′), 60 (P–P″′), and 90 (Q–Q″
′) days of injection immunostained with juxtaparanodal K+ channel (L–Q, red), paranodal
Caspr (L′–Q′, blue), and nodal NfascNF186 (L″–Q″, green). As NfascNF155 levels begin to
decrease (C–E), Caspr localization at the paranodes also decreases, and concomitantly Kv1.1
starts to move toward the node as the paranodal region is getting lost. By 90 days, all of the
Caspr is absent at the paranodes, and the domain organization is lost. R–S″′: Sciatic nerves
from tamoxifen-injected P33 Plp-CreER;NfascFlox mice after 15 of injection immunostained
with juxtaparanodal K+ channel (R,S, red), paranodal Caspr (R′–S′, blue), and nodal
NfascNF186 (R″–S″, green) and in merged images (R″′, S″′). These fibers reveal midstages of
overlap between juxtaparanodal and paranodal components as axoglial junctions are being
compromised. T–W″′: Spinal cord sections from P33 wild-type (T–T″′, +/+) and tamoxifen-
injected P33 Plp-CreER;NfascFlox mice after 20 (U–U″′), 30 (V–V″′) and 60 (W–W″′) days
of injection immunostained with juxtaparanodal K+ channel (T–W, red), paranodal Caspr (T″
′–W′, blue), and nodal NfascNF186 (T″–W″, green) and in merged images (T″′–W″′). Note that,
even in the presence of remaining Caspr at the paranodes, Kv1.1 has already moved next to
the nodal region (W″′), indicating that intact axoglial junctions are required to maintain axonal
domains. X–Z: Immunoblots of spinal cord lysates showing the time course of changes in the
levels of NfascNF155 in Plp-CreER;NfascFlox mice after 10, 20, 40, and 60 days of injection.
Note that NfascNF155 levels begin to fall within 10 days and that by 40 days most of the
NfascNF155 protein is lost (X). On the other hand, protein levels of Caspr (Y) and 4.1B (Z) are
not affected by loss of NfascNF155.
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Axoglial junctions disorganize gradually in NfascNF155AD adult mutants. A: Electron
micrograph of a longitudinal section through the paranodal region of a spinal cord fiber from
P33 wild-type (+/+) mouse shows paranodal loops tightly apposed to and indenting the axon,
forming transverse bands (arrows). The region between the black arrowheads is shown at a
higher magnification in the inset. B–F: Electron micrographs of longitudinal sections through
the paranodal regions of spinal cord nerve fibers from tamoxifen-injected P33 Plp-
CreER;NfascFlox mutants after 20 (B,C), 40 (D,E), and 90 (F) days. At 20 days, transverse
band morphology on the right side is still intact (B, black arrows), but on the left side septa
have become abnormal and diffuse (B, black arrowheads). Other fibers show diffuse transverse
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bands and axolemma detaching from the myelin membrane (C, black arrows, inset). At 40
days, transverse bands remain as unpatterned electron densities (D,E, black arrowheads, insets)
and are essentially absent by 90 days (F, black arrowheads, inset). Axolemmal detachments
from the myelin membrane are also observed during disorganization of the axoglial junctions
(C–F, asterisks). G: Electron micrograph of a longitudinal section through the paranodal region
of a sciatic nerve fiber from P33 wild-type (+/+) mouse shows paranodal loops forming
transverse bands (black arrows). The region between black arrowheads is shown at a higher
magnification in the inset. H–J: Electron micrographs of longitudinal sections through the
paranodal regions of sciatic nerve fibers from tamoxifen-injected Cnp-Cre;NfascFlox mutants
after 20 (H,I) and 90 (J) days. At 20 days, transverse band morphology on the right side is still
intact (H, black arrows), but on the left side the transverse bands have already disappeared (H,
black arrowheads, inset). At a higher magnification (I), absence of transverse bands (asterisks),
diffuse transverse bands, and intact transverse bands are all observed in this fiber. At 90 days,
the transverse bands are essentially absent (J, black arrowheads, inset, asterisks). Note that
some electron densities on the axolemmal side are still present, which may represent the
remaining axonal cytoskeletal complexes at the disorganized paranodes (J, black arrows). Scale
bars = 0.2 µm.
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Peripheral nerve conduction velocities are severely disrupted in NfascNF155 mutants. A,B:
Representative electrophysiological profiles showing A-component CAPs from P13 wild-type
(A, +/+, black) and Cnp-Cre;NfascFlox (A, green) and P16.5 wild-type (B, +/+, black) and
Cnp-Cre;NfascFlox (B, green) mice show severe conduction delay, decrease in amplitude, and
increase in the duration of the action potentials. C: Representative electrophysiological profiles
A-component CAPs from P18 wild-type (+/+, black) and P0-Cre;N-fascFlox (green) mice show
severe conduction delay, decrease in amplitude, and increase in the duration of the action
potentials. Thus Cnp- and P0-Cre-mediated deletion of NfascNF155 independently produce
similar electrophysiological deficits, eliminating any major contributions from the genetic
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backgrounds of these animals. D,E: Representative electrophysiological profiles A-component
of CAP from P112 wild-type (E, +/+, black) and tamoxifen-injected Plp-
CreER;NfascFlox/Flox (E, red) and P213 wild-type and tamoxifen-injected Plp-
CreER;NfascFlox/Flox (F, red) mice show a modest delay in conduction and a minimal decrease
in amplitude.
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Schematic illustrations of the loss of axoglial junctions and failure to maintain axonal domains
in the peripheral myelinated axons. A: Schematic illustration (not to scale) of the axonal
domains in wild-type adult myelinated fibers showing node of Ranvier (green), paranodes
(blue), and juxtaparanodes (red) and internode (aqua). The internodal region contains compact
myelin, and the paranodal region contains loops of noncompact myelin. Molecular interactions
between glial NfascNF155 (pink) and axonal Caspr/contactin (blue) create ladder-like junctions
at the paranodal axon–glia interface. The nodal region where Na+ channels are clustered (green)
is well separated from the K+ channels at the juxtaparanodal region by the paranodes. B–E:
Various stages of domain disorganization after tamoxifen-induced NfascNF155 disruption. The
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levels of paranodal NfascNF155 begin to decrease (B, pink), and axoglial junction
disorganization starts from the juxtaparanodal region, and K+ channels begin to move into the
paranodal region, which begins to get smaller. Axoglial junctions near the nodal region are
still intact. NfascNF155 levels continue to decrease at the paranodes, and more axoglial junctions
have been lost, and paranodal region has become smaller (C). K+ channels continue to move
toward the node. NfascNF155 is undetectable at the paranodes (D), and close to 75% of the
paranode has been lost. K+ channels continue to move toward the node. Paranodes have
disappeared, and K+ channels have reached the nodal region and almost overlap with the nodal
Na+ channels. At all stages, the nodal Na1 channels remain clustered and do not seem to diffuse
into the paranodal area or the axons. (Note that the illustrations are not to scale and reflect
approximate changes in the domain disorganization of the peripheral myelinated axons).
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TABLE II






WT +/+ 16.9 ± 0.09 13 4
NfascNF155 Cnp-Cre/+;
NfascFlox/Flox
9.5 ± 0.97 13 4
WT +/+ 21.75 ± 4.12 21 4
NfascNF155 P0-Cre;
NfascFlox/Flox
12.83 ± 2.86 21 4
WT +/+ 33.50 ± 4.30 86a 2
NfascNF155AD Plp-CreER;
NfascFlox/Flox
25.60 ± 5.60 86a 2
a
Animals were injected at P23 for 10 days and allowed to age to specified time points for electrophysiological measurements.
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